SCHEMBL2589167

SCHEMBL2589167

COc1ccc(OC(N)=O)c(OC)c1C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MAPT P10636 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
TPMT P51580 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
KMT2A Q03164 1/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20148901 0.80 MAPT (0.38) CYP1A2MAPTTDP1CA12CA1
SCHEMBL11649084 0.78 TSHR (0.46) TSHRMAPTTDP1TUBB4ATUBB
SCHEMBL3624482 0.75 NFE2L2 (0.53) TSHRCYP1A2MAPTCA12CA1
SCHEMBL28627336 0.73 KIF11 (0.33) KMT2AHTTLMNA
SCHEMBL31345640 0.73 CES2 (0.36) MAPTKMT2APOLBHTTLMNA
SCHEMBL27947755 0.72 PTGDR2 (0.40) CYP2C19TDP1KMT2AKDM4ESMN1; SMN2
SCHEMBL3230087 0.72 ALDH1A1 (0.37) CYP1A2KMT2APOLBSMN1; SMN2ALDH1A1
SCHEMBL2955217 0.71 CA2 (0.43) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL28474445 0.71 LMNA (0.38) CYP3A4CA12CA1CA2CA4
SCHEMBL29177417 0.70 MEN1 (0.50) MAPTKMT2AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011136385-A1 BICYCLIC COMPOUND DERIVATIVES AND THEIR USE AS ACC INHIBITORS. TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-11-03 WO disclosed